Neuropsychological assessment: A valuable tool in the diagnosis and management of neurological, neurodevelopmental, medical, and psychiatric disorders

Cognitive and Behavioral Neurology

Volumn 24, Issue 3, 2011, Pages 107-114

  Braun, Michelle ^a   Tupper, David ^b   Kaufmann, Paul ^c   McCrea, Michael ^d   Postal, Karen ^e   Westerveld, Michael ^f   Wills, Karen ^g   Deer, Teresa ^h  

^a Wheaton Franciscan Healthcare   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e Neuropsychology Consultants   (United States)

^f FLORIDA HOSPITAL   (United States)

^g CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^h Neuropsychological Consultants   (United States)

Author keywords

clinical management; diagnosis; neurodevelopmental disorders; neurological disorders; neuropsychological assessment

Indexed keywords

DONEPEZIL; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; BRAIN TUMOR; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; DEMENTIA; DEVELOPMENTAL DISORDER; EPILEPSY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; INTRACRANIAL ANEURYSM; LEGAL ASPECT; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STROKE; TRAUMATIC BRAIN INJURY;

DEVELOPMENTAL DISABILITIES; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS;

EID: 80053430817     PISSN: 15433633     EISSN: 15370887     Source Type: Journal    
DOI: 10.1097/WNN.0b013e3182351289     Document Type: Review

References (160)

1. Temple RO, Carvalho J, Tremont G. A national survey of physicians' use of and satisfaction with neuropsychological services. Arch Clin Neuropsychol. 2006;21:371-382. (Pubitemid 44247517)
2. Matarazzo J. Psychological assessment versus psychological testing: Validation from Binet to the school, clinic, and courtroom. Am Psychol. 1990;45:999-1017.
3. Meyer G, Finn S, Eyde L, et al. Psychological testing and psychological assessment: A review of evidence and issues. Amer Psychol. 2001;56:128-165 (Pubitemid 33624315)
4. Chaytor N, Schmitter-Edgecombe M. The ecological validity of neuropsychological tests: A review of the literature on everyday cognitive skills. Neuropsychol Rev. 2003;13:181-197. (Pubitemid 39012557)
5. Gure TR, Kabeto MU, Plassman BL, et al. Differences in functional impairment across subtypes of dementia. J Gerontol: Biolog Sci Med Sci. 2010;65:434-441.
6. Marcotte TD, Grant I. Neuropsychology of Everyday Functioning. New York: Guilford; 2010.
7. Stilley CS, Bender CM, Dunbar-Jacob J, et al. The impact of cognitive function on medication management: Three studies. Health Psychol. 2010;29:50-55.
8. Sbordone RJ, Long CJ. Ecological Validity of Neuropsychological Testing. New York: CRC Press; 1996.
9. Wilson BA. Ecological validity of neuropsychological assessment: Do neuropsychological indexes predict performance in everyday activities? Appl Prev Psychol. 1999;2:209-215.
10. Cullum CM, Thompson LL, Smernoff EM. Three word recall as a measure of memory. J Clin Exp Neuropsychol. 1993;15:321-329. (Pubitemid 23156215)
11. American Academy of Neurology. Report of the Therapeutics and Technology Assessment Subcommittee. Assessment: Neuropsychological testing of adults. Considerations for neurologists. Neurology. 1996;47:592-599.
12. Salmon DP, Bondi MW. Neuropsychological assessment of dementia. Annu Rev Psychol. 2009;60:257-282.
13. Benedict RH, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. J Neurol. 2007;254(suppl 2):II22-II25.
14. Hermann B, Seidenberg M, Lee EJ, et al. Cognitive phenotypes in temporal lobe epilepsy. J Int Neuropsychol Soc. 2007;13:12-20. (Pubitemid 46487371)
15. Godefroy O, Roussel M, Leclerc X, et al. Deficit of episodic memory: Anatomy and related patterns in stroke patients. Eur Neurol. 2009;61:223-229.
16. Muslimovic D, Post B, Speelman JD, et al. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurol. 2005; 65:1239-1245. (Pubitemid 41508217)
17. Babikian T, Asarnow R. Neurocognitive outcomes and recovery after pediatric TBI: Meta-analytic review of the literature. Neuropsychol. 2009;23:283-296.
18. McCrea M, Iverson GL, McAllister TW, et al. An integrated review of recovery after mild traumatic brain injury (MTBI): Implications for clinical management. Clin Neuropsychol. 2009;23:1368-1390.
19. Yeates KO, Bigler ED, Dennis M, et al. Social outcomes in childhood brain disorder: A heuristic integration of social neuroscience and developmental psychology. Psychol Bull. 2007;133: 535-556.
20. Meyers CA, Brown PD. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. J Clin Oncol. 2006;24:1305-1309. (Pubitemid 46622034)
21. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: Test selection, reliability, and validity. Am J Psychiatry. 2008;165:203-213. (Pubitemid 351704520)
22. Frazier TW, Demaree HA, Youngstrom EA. Meta-analysis of intellectual and neuropsychological test performance in attentiondeficit/ hyperactivity disorder. Neuropsychology. 2004;18:543-555. (Pubitemid 38944390)
23. Jones BL, Eberle JA. Learning disabilities: Diagnostic considerations from an educational perspective. Semin Clin Neuropsychiatr. 2000;5:157-163.
24. Ris MD, Ammerman RT, Waller N, et al. Taxonicity of nonverbal learning disabilities in spina bifida. J Int Neuropsychol Soc. 2007;13:50-58. (Pubitemid 46487375)
25. Chan AS, Sze SL, Cheung MC. Neuroanatomical basis in the temporal lobes for processing living things. Neuropsychology. 2004;18:700-709. (Pubitemid 39363156)
26. Posner J, Stewart J, Rieder R. Neurobiological formulations: Integrating clinical and biological psychiatry. Acad Psychiatr. 2007;31:479-484.
27. Attix DK, Story TJ, Chelune GJ, et al. The prediction of change: Normative neuropsychological trajectories. Clin Neuropsychol. 2009;23:21-38.
28. Sawrie SM, Chelune GJ, Naugle RI, et al. Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery. J Int Neuropsychol Soc. 1996;2:556-564. (Pubitemid 126449822)
29. Heilbronner RL, Sweet JJ, Morgan JE, et al. American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering. Clin Neuropsychol. 2009;23:1093-1129.
30. Fletcher J, Shaywitz S, Shaywitz B. Comorbidity of learning and attention disorders: Separate but equal. Pediatr Clinics N Am. 1999;46:885-897. (Pubitemid 29477879)
31. Schatz D, Rostain A. ADHD with comorbid anxiety : A review of the current literature. J Attention Disorders. 2006;10:141.
32. Pfiffner L, McBurnett K. Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder. J Abnorm Ch Psychol. 2006;34:725-735.
33. Rourke B. Neuropsychological assessment of children with learning disabilities. In: Lyon G, ed. Frames of Reference for the Assessment of Learning Disabilities. Baltimore: Brookes; 1994.
34. Humphrey L, Satz P. The use of neuropsychological assessment in clarifying the educational needs of children with learning disabilities. In: Prigatano G, Pliskin N, eds. Clinical Neuropsychology and Outcomes Research. New York: Psychology Press; 2003.
35. Geroldi C, Canu E, Bruni AC, et al. The added value of neuropsychologic tests and structural imaging for the etiologic diagnosis of dementia in italian expert centers. Alz Dis Assoc Dis. 2008;22:309-320.
36. Hentschel F, Kreis M, Damian M, et al. The clinical utility of structural neuroimaging with MRI for diagnosis and differential diagnosis of dementia: A memory clinical study. Int J Geriatr Psychiatr. 2005;20:645-650. (Pubitemid 41131774)
37. Gilman S, Koeppe RA, Little R, et al. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with (18F) fluorodeoxyglucose and neuropsychological testing. Exper Neurol. 2005;191:S95-S103. (Pubitemid 40081108)
38. Oda H, Yamamoto Y, Maeda K. Neuropsychological profile of dementia with Lewy bodies. Psychogeriatr. 2009;9:85-90.
39. Robottom BJ, Weiner WJ. Dementia in Parkinson's disease. Int Rev Neurobiol. 2009;84:229-244.
40. American Academy of Clinical Neuropsychology. AACN Response to AMA/PCPI Dementia Performance Measurement Set. 2010. Retrieved 7/26/2011 from http://theaacn.org/position-papers/AA CNresponse-to-AMA-PCPI-Dementia- Performance-Measurement-Set.pdf.
41. Smith GE, Ivnik RJ, Lucas JA. Assessment techniques: Tests, test batteries, norms, and methodological approaches. In: Morgan J, Ricker J, eds. Textbook Clin Neuropsychol. New York: Taylor & Francis Group; 2008.
42. Ferman TJ, Smith GE, Boeve GF, et al. Neuropsychological differentiation of dementia with Lewy Bodies from normal aging and Alzheimer's disease. Clin Neuropsychol. 2006;20:623-636. (Pubitemid 44410540)
43. Gavett B, Poon SJ, Ozonoff A, et al. Diagnostic utility of the NAB List Learning test in Alzheimer's disease and amnestic mild cognitive impairment. J Int Neuropsychol Soc. 2009;15:121-129.
44. Gavett B, Ozonoff A, Doktor V, et al. Predicting cognitive decline and conversion to Alzheimer's disease in older adults using the NAB List Learning test. J Int Neuropsychol Soc. 2010;16:651-660.
45. Libon DJ, Xie SX, Moore P, et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurol. 2007;68:369-375. (Pubitemid 46184214)
46. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidencebased review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurol. 2001;56:1133.
47. Wright SL, Persad C. Distinguishing between depression and dementia in older persons: Neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol. 2007;20:189-198. (Pubitemid 350077300)
48. Tierney MC, Yao C, Kiss A, et al. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurol. 2005;64:1853-1859. (Pubitemid 40800697)
49. de Jager CA, Schrijnemaekers AC, Honey TE, et al. Detection of MCI in the clinic: Evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. Age Ageing. 2009;38:455-460.
50. Hanna-Pladdy B, Enslein A, Fray M, et al. Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: Comparison with the MMSE and the MoCA. Inter J Neurosci. 2010;120:538-543.
51. Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurol. 2009;73:1738-1745.
52. O'Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the Mini-Mental State Examination in highly educated individuals. Arch Neurol. 2008;65:963-967. (Pubitemid 352008482)
53. Stephan BC, Kurth T, Matthews FE, et al. Dementia risk prediction in the population: Are screening models accurate? Nat Rev Neurol. 2010;6:318-326.
54. Cummings J, Jones R, Wikinson D, et al. Effect of donepezil on cognition in Alzheimer's disease: A pooled data analysis. J Alzheimer's Dis. 2010;21:843-851.
55. Farias ST, Harrell E, Neumann C, et al. The relationship between neuropsychological performance and daily functioning in individuals with Alzheimer's disease: Ecological validity of neuropsychological tests. Arch Clin Neuropsychol. 2003;18:655-672. (Pubitemid 36945503)
56. Razani J, Bayan S, Funes C, et al. Patterns of deficits in daily functioning and cognitive performance of patients with Alzheimer disease. J Geriatr Psychiatr Neurol. 2011;24:23-32.
57. Cosentino S, Metcalfe J, Cary M, et al. Memory awareness influences everyday decision making capacity about medication management in Alzheimer's disease. Int J Alzheimer's Dis. 2011. Article ID 483897, 9 pages.
58. Mendez MF, Shapira JS, McMurtray A, et al. Preliminary findings: Behavioral worsening on donepezil patients with frontotemporal dementia. Am J Geriat Psychiatr. 2007;15:84-87. (Pubitemid 46106094)
59. Weimer D, Sager M. Early identification of Alzheimer's disease: Social and fiscal outcomes. Alzheimers Dement. 2009;5:215-226.
60. Hermann N, Lanctôt K. Memantine in dementia: A review of the current evidence. Expert Opin Psychother. 2011;12:787-800.
61. Morgan JE, Ricker JH. Textbook of Clinical Neuropsychology. New York: Taylor & Francis; 2008.
62. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Inter Med. 2004;256:183-194. (Pubitemid 39222988)
63. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alz & Dem. 2011;7:280-292.
64. Di Legge S, Hashinski V. Vascular cognitive Impairment (VCI): Progress towards knowledge and treatment. Dementia & Neuropsychol. 2010;4:4-13.
65. Jak AJ, Bondi MW, Delano-Wood L, et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am J Geriatr Psychiatr. 2009;17:368-375.
66. Nordlund A, Rolstad S, Klang O, et al. Cognitive profiles of mild cognitive impairment with and without vascular disease. Neuropsychol. 2007;21:706-712. (Pubitemid 350116514)
67. Baars MAE, van Bostel MPJ, Dijkstra JB, et al. Predictive value of mild cognitive impairment for dementia. Dement Geriatr Cogn Dis. 2009;27:173-181.
68. Kim SH, Yoon DS, Chin J, et al. Comparison of neuropsychological and FDG-PET findings between early-versus late-onset mild cognitive impairment: A five-year longitudinal study. Dementia Geriatr Cog Dis. 2010;29:213-223.
69. Spaan PEJ, Dolan CV. Cognitive decline in normal aging and early Alzheimer's disease: A continuous or discontinuous transition? Behav Neurol. 2010;23:203-206.
70. Tabert MH,Manly J, Liu X, et al. Neuropsychological prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment. Arch Gen Psychiatr. 2006;63:916-924. (Pubitemid 44188484)
71. Visser PJ, Verhey F, Knol DL, et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment of mild cognitive impairment in the DESCRIPA study: A prospective cohort study. Lancet Neurol. 2009;8:619-627.
72. Balthazar MLF, Yasuda CL, Cendes F, et al. Learning, retrieval, and recognition are compromised in aMCI and mild AD: Are distinct episodic memory processes mediated by the same anatomical structures? J Int Neuropsychol Soc. 2010;16:205-209.
73. Jak AJ, Urban S, McCauley A, et al. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc. 2009;15: 890-897.
74. Triebel KL, Martin R, Griffith HR, et al. Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurol. 2009;73:928-934.
75. Diller L. Introduction to the special section on neuropsychology and rehabilitation: The view from New York University. Neuropsychology. 1992;6:357-359.
76. Novack TA. Neuropsychological practice in rehabilitation. In: Frank RG, Rosenthal M, Caplan B, eds. Handbook of Rehabilitation Psychology. Washington DC: American Psychological Association; 2010.
77. Rohling ML, Faust ME, Beverly B, et al. Effectiveness of cognitive rehabilitation following acquired brain injury: A meta-analytic reexamination of Cicerone et al's (2000, 2005) systematic reviews. Neuropsychol. 2009;23:20-39.
78. Toniolo S. Neuropsychological interventions in stroke survivors: Implications for evidence based psychological practice. G Ital Med Lav Ergon. 2011;33:A29-A36.
79. Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41:519-536.
80. Barker-Collo S, Feigin VL. The impact of neuropsychological deficits on functional stroke outcomes. Neuropsychol Rev. 2006;16:53-64. (Pubitemid 44386777)
81. Devos H, Akinwuntan AE, Nieuwboer A, et al. Screening for fitness to drive after stroke: A systematic review and meta-analysis. Neurology. 2011;76:747-756.
82. Feigin VL, Barker-Collo S, McNaughton H, et al. Long-term neuropsychological and functional outcomes in stroke survivors: Current evidence and perspectives for new research. Int J Stroke. 2008;3:33-40. (Pubitemid 351228143)
83. Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9:895-905.
84. Leung AWS, Cheng SKW, Mak AKY, et al. Functional gain in hemorrhagic stroke patients is predicted by functional level and cognitive abilities measured at hospital admission. Neuro Rehabil. 2010;27:351-358.
85. Wagle J, Farner L, Flekkøy K, et al. Early post-stroke cognition in stroke rehabilitation patients predicts functional outcome at 13 months. Dement Geriatr Cogn Disord. 2011;31:379-387.
86. Barker-Collo S, Feigin VL, Parag V, et al. Auckland stroke outcomes study: Part 2: Cognition and functional outcomes 5 years poststroke. Neurol. 2010;75:1608-1616.
87. Hanks RA, Millis SR, Ricker JH, et al. The predictive validity of a brief inpatient neuropsychologic battery for persons with traumatic brain injury. Arch Phys Med Rehabil. 2008;89:950-957. (Pubitemid 351602267)
88. Miller LJ, Donders J. Prediction of educational outcome after pediatric traumatic brain injury. Rehabilit Psychol. 2003;48:237-241. (Pubitemid 37392698)
89. Bercaw EL, Hanks RA, Millis SR, et al. Changes in neuropsychological performance after traumatic brain injury from inpatient rehabilitation to 1-year follow-up in predicting 2-year functional outcomes. Clin Neuropsychol. 2011;25:72-89.
90. Dikmen SS, Machamer JE, Powell JM, et al. Outcome 3 to 5 years after moderate to severe traumatic brain injury. Arch Phys Med Rehabil. 2003;84:1449-1457. (Pubitemid 37237252)
91. Ehlardt L, Sohlberg MM, Kennedy MRT, et al. Evidence-based practice guidelines for instructing individuals with acquired memory impairments: What have we learned in the past 20 years? Neuropsychol Rehabil. 2008;18:300-342. (Pubitemid 351874172)
92. Kennedy MRT, Coelho C, Turkstra L, et al. Intervention for executive functions after traumatic brain injury: A systematic review, meta-analysis and clinical recommendations. Neuropsychol Rehabilit. 2008;18:257-299. (Pubitemid 351874173)
93. Lundqvist A, Alinder J, Rönnberg J. Factors influencing driving 10 years after brain injury. Brain Inj. 2008;22:295-304. (Pubitemid 351448001)
94. Morris DM, Shaw SE, Mark VW, et al. The influence of neuropsychological characteristics on the use of CI therapy with persons with traumatic brain injury. Neuro Rehabil. 2006; 21:131-137. (Pubitemid 44253287)
95. Reid-Arndt SA, Nehl C, Hinkebein J. The Frontal Systems Behaviour Scale (FrSBe) as a predictor of community integration following a traumatic brain injury. Brain Inj. 2007;21:1361-1369. (Pubitemid 350253440)
96. Rassovsky Y, Satz P, Alfano MS, et al. Functional outcome in TBI II: Verbal memory and information processing speed mediators. J Clin Exper Neuropsychol. 2006;28:581-591.
97. Goldstein FC, Levin HS. Neurobehavioral outcome of traumatic brain injury in older adults: Initial findings. J Head Tr Rehabilit. 1995;10:57-73.
98. Stapert S, Houx P, De Kruijk J, et al. Neurocognitive fitness in the sub-acute stage after mild TBI: The effect of age. Brain Inj. 2006;20:161-165. (Pubitemid 43158179)
99. Clusmann H. Predictors, procedures, and perspective for temporal lobe epilepsy surgery. Semin Ultrasound CT MR. 2008;29:60-70. (Pubitemid 351625611)
100. Helmstaedter C. Neuropsychological aspects of epilepsy surgery. Epilepsy Behav. 2004;5:S45-S55. (Pubitemid 38937082)
101. Henry TR, Roman DD. Presurgical epilepsy localization with interictal cerebral dysfunction. Epilepsy Behav. 2011;20:194-208.
102. Hermann BP, Seidenberg M, Dow C, et al. Cognitive prognosis in chronic temporal lobe epilepsy. Ann Neurol. 2006;60:80-87.
103. Quiske A, Unterrainer J, Wagner K, et al. Assessment of cognitive functions before and after sterotactic interstitial radiosurgery of hypothalamic hamartomas in patients with gelastic seizures. Epilepsy Behav. 2007;10:328-332. (Pubitemid 46432234)
104. Sabsevitz DS, Swanson SJ, Morris GL, et al. Memory outcome after left anterior temporal lobectomy in patients with expected an reversed Wada memory asymmetry scores. Epilepsy. 2001;41: 1408-1415. (Pubitemid 33140616)
105. Graydon FJX, Nunn JA, Polkey CE, et al. Neuropsychological outcome and the extent of resection in the unilateral temporal lobectomy. Epilepsy Behav. 2001;2:140-151. (Pubitemid 33585782)
106. Sirven JI, Malamut BL, O'Connor MJ, et al. Temporal lobectomy outcome in older versus younger adults. Neurology. 2000;54: 2166-2169. (Pubitemid 30397224)
107. Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev. 2007;17:413-425. (Pubitemid 350231552)
108. Martin RU, Meador K, Turrentine L, et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia. 2001;42:764-771. (Pubitemid 32605939)
109. Flensborg DM, ShevlinM, Borghammer P, et al. Clinical heterogeneity in Parkinson's disease revisited: A latent profile analysis. Acta Neurol Scand. doi: 10.1111/j.1600-0404.2011.01561.x. [Epub ahead of print]
110. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: An expert consensus and review of key issues. Arch Neurol. 2011;68:165.
111. Okun MS, Rodriguez RL, Mikos A, et al. Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol. 2007;21:162-189. (Pubitemid 46277802)
112. Trepanier LL, Kumar R, Lozano A, et al. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson's disease. Brain Cogn. 2000;42:324-347. (Pubitemid 30210929)
113. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain. 2010;133:2664-2676.
114. Naskar S, Sood SK, Goyal V, et al. Mechanism(s) of deep brain stimulation and insights into cognitive outcomes in Parkinson's disease. Brain Res Rev. 2010;65:1-13.
115. Robins Wahlin T, Lundin A, Dear K. Early cognitive deficits in Swedish gene carriers of Huntington's disease. Neuropsychology. 2007;21:31-44. (Pubitemid 46066205)
116. Duinkerke A, Williams MA, Rigamonti D, et al. Cognitive recovery in idiopathic normal pressure hydrocephalus after shunt. Cogn Behav Neurol. 2004;17:179-184. (Pubitemid 39238366)
117. Gustaw-Rothenberg K. Cognitive impairment after tick-borne encephalitis. Dement Geriatr Cogn Disord. 2008;26:165-168.
118. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurol. 2008;71:632-638.
119. Kalmar JH, Gaudino EA, Moore NB, et al. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychol. 2008;22:442-449. (Pubitemid 351992891)
120. Masson JD, Dagnan D, Evans J. Adaptation and validation of the Tower of London test of planning and problem solving in people with intellectual disabilities. J Intell Disabil Res. 2010;54:457-467.
121. Talacchi A, Santini B, Savazzi S, et al. Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol. 2011; 103:541-549.
122. Towgood K, Ogden JA, Mee E. Neurological, neuropsychological, and psychosocial outcome following treatment of unruptured intracranial aneurysms: A review and commentary. J Int Neuropsychol Soc. 2004;10:114-134. (Pubitemid 38128469)
123. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263-1269.
124. Cohen RA, Gunstad J. Neuropsychology and Cardiovascular Disease. New York: Oxford University Press; 2010.
125. Kalirao P, Pederson S, Foley RN, et al. Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis. 2011;57:612-620.
126. Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurol. 2006; 67:216-223. (Pubitemid 44305402)
127. Waldstein SR, Wendell CR. Neurocognitive function and cardiovascular disease. J Alzheimers Dis. 2010;20:833-842.
128. Waldstein SR, Wendell CR, Hosey MM, et al. Cardiovascular disease and neurocognitive function. In: Armstrong CL, Morrow L, eds. Handbook of Medical Neuropsychology. New York: Springer; 2010:69-100.
129. Gasquoine PG. Cognitive impairment in common, noncentral nervous system medical conditions of adults and the elderly. J Clin Exper Neuropsychol. 2011;4:486-496.
130. Antony SP, Jamuna R, Kini SM, et al. Neuropsychological deficits in patients with myocardial infarction. Neuropsychol Trends. 2010;7:37-50.
131. Jerskey BA, Cohen RA, Jefferson AL, et al. Sustained attention is associated with left ventricular ejection fraction in older adults with heart disease. J Int Neuropsychol Soc. 2009;15:137-141.
132. Hoth KF, Poppas A, Moser DJ, et al. Cardiac dysfunction and cognition in older adults with heart failure. Cognit Behav Neurol. 2008;21:65-72.
133. Ylikoski R, Ylikoski A, Raininko R, et al. Cardiovascular diseases, health status, brain imaging findings and neuropsychological functioning in neurologically healthy elderly individuals. Arch Gerontol Geriatr. 2000;30:115-130. (Pubitemid 30227472)
134. Weinberg DG, Rahme RJ, Aoun SG, et al. Moyamoya disease: Functional and neurocognitive outcomes in the pediatric and adult populations. Neurosurg Focus. 2011;30:E21.
135. Lim C, Alexander MP, LaFleche G, et al. The neurological and cognitive sequelae of cardiac arrest. Neurology. 2004;63:1774-1778. (Pubitemid 39532368)
136. McLennan SN, Mathias JL, Brennan LC, et al. Cognitive impairment predicts functional capacity in dementia-free patients with cardiovascular disease. J Cardiovasc Nurs. 2010;25:390-397.
137. Alosco ML, Spitznagel MB, Cohen R, et al. Cognitive impairment is independently associated with reduced instrumental activities of daily living in persons with heart failure. J Cardiovasc Nurs. 2011. [Epub ahead of print]
138. Edwards CL, Raynor RD, Feliu M, et al. Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD). Neuropsychiatric Disord Treat. 2007;3:705-709.
139. Gold JI, Johnson CB, Treadwell MJ, et al. Detection and assessment of stroke in patients with sickle cell disease: Neuropsychological functioning and magnetic resonance imaging. Pediatr Hematol Oncol. 2008;25:409-421. (Pubitemid 351874093)
140. von Rhein M, Scheer I, Loenneker T, et al. Structural brain lesions in adolescents with congenital heart disease. J Pediatr. 2011; 158:984-989.
141. Areza-Fegyveres R, Kairalla RA, Carvalho CRR, et al. Cognition and chronic hypoxia in pulmonary diseases. Dement Neuropsychol. 2010;4:14-22.
142. Sachdev PS, Anstey KJ, Parslow RA, et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dement Geriatr Cogn Disord. 2006;21:300-308. (Pubitemid 43735674)
143. Randolph C, Hilsabeck R, Kato A, et al. International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629-635.
144. Kozora E, Ellison MC, West S. Reliability and validity of the proposed American college of rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum Arthritis Care Res. 2004;51:810-818. (Pubitemid 39372041)
145. Gorman AA, Foley JM, Ettenhofer ML, et al. Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev. 2009;19:186-203.
146. Scott JC, Woods SP, Vigil O, et al. A neuropsychological investigation of multitasking in HIV infection: Implications for everyday functioning. Neuropsychology. 2011;25:511-519.
147. Gelb SR, Shapiro RJ, Thornton WJ. Predicting medication adherence and employment status following kidney transplant: The relative utility of traditional and everyday cognitive approaches. Neuropsychology. 2010;24:514-526.
148. Messier C, Tsiakas M, Gagnon M, et al. Effect of age and glucoregulation on cognitive performance. J Clin Exper Neuropsychol. 2010;32:809-821.
149. Zihl J, Shaaf L, Zillmer EA. The relationship between adult neuropsychological profiles and diabetic patients' glycemic control. Appl Neuropsychol. 2010;17:44-51.
150. Knopman DS, Mosley TH, Catellier DJ, et al. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARICMRI study. Alzheimer Dement. 2009;5:207-214.
151. Smith GE, Bondi M, Steinmetz J, et al. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009;110: 548-555.
152. Steinmetz J, Christensen KB, Lund T, et al. Postoperative cognitive decline. J Anesth. 2009;23:256-259.
153. Eack SM, Pogue-Geile MF, Greenwald DP, et al. Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia. Psychol Med. 2010;22:1-9.
154. Shrivastava A, Johnston M, Shah N, et al. Persistent cognitive dysfunction despite clinical improvement in schizophrenia: A 10-year follow-up study. J Psychiatr Pract. 2011;17:194-199.
155. Bearden CE, Woogen M, Glahn DC. Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder. Curr Psychiatry Rep. 2010;12:499-504.
156. Depp CA, Cain AE, Palmer BW, et al. Assessment of medication management ability in middle-aged and older adults with bipolar disorder. J Clin Psychopharmacol. 2008;28:225-229. (Pubitemid 351417130)
157. Martino DJ, Igoa A, Marengo E, et al. Neurocognitive impairments and their relationship with psychosocial functioning in euthymic bipolar II disorder. J Nerv Ment Dis. 2011;199:459-464.
158. Mackin RS, Arean PA. Impaired financial capacity in late life depression is associated with cognitive performance on measures of executive functioning and attention. J Int Neuropsychol Soc. 2009;15:793-798.
159. Simmons v. Mullen, 331 A.2d 892, 897 (Pa. Super. Ct., 1974). http://pa.findacase.com/research/wfrmDocViewer.aspx/xq/fac. 19741211-0042128.PA. htm/qx.
160. Kaufmann PM. Protecting raw data and psychological tests from wrongful disclosure: A primer on the law. Clin Neuropsychol. 2009;23:1130-1159.